Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ASTOMED AS
AS
Active
Org 928730824
Strandveien 55, 1366 Lysaker
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
3 employees
www.astomed.no
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 15,6M
+3% vs 2023
EBITDA margin
3.6%
-74% vs 2023
Equity ratio
8.9%
Financial strength
Net profit 2024
NOK 50K
-97% vs 2023
EBITDA — year on year
NOK millions
3M
2M
1M
1M
0M
0M
2022
2M
+200%
2023
1M
-50%
2024
Key figures
Annual report 2024
Revenue
NOK 15,6M
+3%
EBITDA
NOK 561K
-74%
Net profit
NOK 50K
-97%
Total assets
NOK 3,9M
-43%
Equity
NOK 345K
-80%
Employees
3
—
Company information
Legal name
ASTOMED AS
Org number
928730824
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. mars 2022
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Handel innen produkter benyttet til estetisk medisin og lignende, samt konsulentvirksomhet innen samme område.
Contact
Address
Strandveien 55, 1366 Lysaker
Website
www.astomed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Bærum
All Norway companies
Revenue
NOK millions
0M
5M
9M
14M
18M
6M
2022
15M
2023
16M
2024
EBITDA
NOK millions
0M
1M
1M
2M
2M
0M
2022
2M
2023
1M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
6 256
15 159
15 602
Staff expenses
−311
−1 654
−2 566
EBITDA
202
2 179
561
Depreciation & amort.
−40
−50
−297
EBIT
162
2 129
265
Net financials
0
−246
−197
Profit before tax
163
1 883
67
Tax
36
414
17
Net profit
127
1 468
50
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
4 255
6 807
3 858
Equity
227
1 695
345
Long-term debt
0
0
0
Short-term debt
4 028
5 112
3 513
Total debt
4 028
5 112
3 513
Financial ratios
5-year trend
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
2022
2024
Equity ratio
8.9%
This company
38.2%
Market median
-77% vs market
2022
2024
Return on equity
14.6%
This company
18.4%
Market median
+21% vs market
2022
2024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
2022
2024
Asset turnover
4.04×
This company
1.12×
Market median
+261% vs market
2022
2024
Debt / equity
10.18×
This company
0.62×
Market median
-1542% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-02 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TG
Torstein Greibrokk
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TJ
Thomas Joakim Mangs
Board of Directors
2022
KJ
Kristina Josefina Melinda Mangs
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Riwimato As
Company
50%
50%
2022
Astomed Holding Ab
Company
50%
50%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ASTOMED AS also hold positions in
0
other companies.
Person
Role here
Other companies
Torstein Greibrokk
Chief Executive Officer
0 companies
Thomas Joakim Mangs
Board of Directors
0 companies
Kristina Josefina Melinda Mangs
Board of Directors
0 companies